Anuh Pharma Limited (ANUHPHR) Stock Statistics & Valuation Metrics

Anuh Pharma Limited has a market cap or net worth of ₹7.89B. The enterprise value is ₹7.91B.

Anuh Pharma Limited has 100,224,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Anuh Pharma Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 10.75%.

The current PE Ratio of Anuh Pharma Limited is 19.2. Anuh Pharma Limited’s PEG ratio is -1.25.

In the last 12 months, Anuh Pharma Limited had revenue of 7.72B and earned 410.46M in profits. Earnings per share was 4.10.

In the last 12 months, operating cash flow was 121.88M and capital expenditures -180.40M, giving a free cash flow of -58.52M billion.

Anuh Pharma Limited pays an annual dividend of ₹1.5, resulting in a dividend yield of 1.92%

Anuh Pharma Limited upcoming earnings date is Aug 7, 2026, TBA (Confirmed).

Anuh Pharma Limited as a current ratio of 2.22, with Debt / Equity ratio of 0.02%

In the past 12 months, Anuh Pharma Limited has paid 131.75M in taxes.

Anuh Pharma Limited EV to EBITDA ratio is 10.04, with an EV/FCF ratio of -61.22.

Anuh Pharma Limited has ₹135.33M in cash and marketable securities with ₹2.27M in debt, giving a net cash position of ₹133.05M billion.

Gross margin is 19.79%, with operating margin of 6.52%, and net profit margin of 5.32%.

The average price target for Anuh Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―